Abstracts

Discover the poster that reaffirm Ipsen’s commitment to patients with Prostate cancer.

Survivorship in prostate cancer: It is all about patients

16th March
2018

73 - Evolution of quality of life of partners of patients suffering from prostate cancer (PCa) receiving gonadotropin-releasing hormone (GnRH) agonist treatment

Friday 16th March / 10:45 - 12:15

Poster session 06

Aurélien Descazeaud1, Nathalie Pello-Leprince-Ringuet2, Valérie Perrot2, Stéphane Droupy3

1. Urology department, University Hospital, Limoges, France
2. IPSEN Pharma, Boulogne-Billancourt, France
3. Urology Andrology department, CHU Caremeau, Nîmes, France